BeStock  
股票 › 生物科技 › XENE

氙制药 XENE

美股市值排名 #2302生物科技
$39.17 +$1.49 (+3.95%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $39.39 +0.56%
开盘$37.80
昨收$37.68
当日区间$37.15 – $39.21
成交量869.7K
市值$3.79B
市盈率(TTM)–
股息率–

基本面

最新报告季度:Q2, ended Jun 2026

营收$0.00
营业利润-$123.16M-30.7% YoY
净利润-$110.74M-30.7% YoY
摊薄每股收益-$1.11-3.7% YoY
自由现金流-$95.67M-48.6% YoY
经营现金流-$95.39M

营收,近8个季度

$0.0Sep '24$0.0Dec '24$7.5MMar '25$0.0Jun '25$0.0Sep '25$0.0Dec '25$0.0Mar '26$0.0Jun '26

净利润,近8个季度

$-62.8MSep '24$-65.7MDec '24$-65.0MMar '25$-84.7MJun '25$-90.9MSep '25$-105.3MDec '25$-102.3MMar '26$-110.7MJun '26

各季度摊薄每股收益

-0.81Sep '24-0.84Dec '24-0.83Mar '25-1.07Jun '25-1.15Sep '25-1.31Dec '25-1.17Mar '26-1.11Jun '26

各季度自由现金流

$-50.3MSep '24$-55.2MDec '24$-61.7MMar '25$-64.4MJun '25$-72.0MSep '25$-81.8MDec '25$-89.0MMar '26$-95.7MJun '26

年度营收

$32.2MFY20$18.4MFY21$9.4MFY22$0.0FY23$0.0FY24$7.5MFY25

盈利能力与资产负债表

净资产收益率-43.6%
资产收益率-41.5%
投入资本回报率-46.5%
流动比率21.02
负债/资产比率4.1%
现金及投资$930.69M
总负债$5.08M
净现金(净负债)$925.61M

利润表

项目 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
报告营业总收入 $0.00 $0.00 $7.50M $0.00 $0.00
营业总收入 $0.00 $0.00 $7.50M $0.00 $0.00
营业费用 $123.16M $112.33M $380.57M $109.77M $96.34M
销售及管理费用 $23.93M $23.82M $79.63M $22.07M $19.28M
-管理费用 $23.93M $23.82M $79.63M $22.07M $19.28M
研发费用 $99.22M $88.51M $300.94M $87.70M $77.05M
营业利润 -$123.16M -$112.33M -$373.07M -$109.77M -$96.34M
非经营性利息净收入(支出) $12.15M $6.91M $26.83M $5.34M $6.21M
非经营性利息收入 $12.15M $6.91M $26.83M $5.34M $6.21M
其他收入(支出) -$311,000.00 $548,000.00 $1.35M -$296,000.00 -$89,000.00
证券出售收益 -$311,000.00 $548,000.00 $1.35M -$296,000.00 -$89,000.00
税前利润 -$111.32M -$104.87M -$344.89M -$104.72M -$90.22M
税费 -$585,000.00 -$2.57M $1.02M $538,000.00 $677,000.00
净利润 -$110.74M -$102.30M -$345.91M -$105.26M -$90.90M
持续经营利润 -$110.74M -$102.30M -$345.91M -$105.26M -$90.90M
归属母公司净利润 -$110.74M -$102.30M -$345.91M -$105.26M -$90.90M
归属普通股股东净利润 -$110.74M -$102.30M -$345.91M -$105.26M -$90.90M
基本每股收益 -$1.11 -$1.17 -$4.36 -$1.31 -$1.15
摊薄每股收益 -$1.11 -$1.17 -$4.36 -$1.31 -$1.15

资产负债表

项目 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
总资产 $1.30B $1.39B $633.16M $633.16M $607.84M
流动资产合计 $945.87M $1.11B $560.65M $560.65M $480.14M
现金及现金等价物与短期投资 $930.69M $1.09B $548.89M $548.89M $462.27M
-现金及现金等价物 $119.53M $545.87M $199.16M $199.16M $104.51M
-短期投资 $811.16M $548.88M $349.72M $349.72M $357.75M
应收款 $1.63M $1.17M $1.37M $1.37M $812,000.00
-应收账款 $1.63M $1.17M $1.37M $1.37M $812,000.00
其他流动资产 $13.55M $10.72M $10.39M $10.39M $17.06M
非流动资产合计 $349.90M $280.18M $72.51M $72.51M $127.70M
固定资产净值 $13.16M $14.58M $15.35M $15.35M $15.85M
-固定资产原值 $13.16M $14.58M $30.80M $30.80M $15.85M
投资及预付款 $314.41M $244.87M $37.15M $37.15M $92.99M
-可供出售证券 $314.41M $244.87M $37.15M $37.15M $92.99M
一年以上预付资产 $7.97M $8.31M $7.15M $7.15M $7.11M
一年以上递延资产 $14.36M $12.42M $12.86M $12.86M $11.75M
负债合计 $53.38M $48.99M $51.40M $51.40M $48.33M
流动负债合计 $45.01M $39.82M $41.79M $41.79M $38.34M
应付款 $3.42M $6.02M $4.20M $4.20M $4.79M
-应付账款 $2.48M $5.75M $3.89M $3.89M $4.55M
-应付税款合计 $935,000.00 $269,000.00 $313,000.00 $313,000.00 $231,000.00
一年内应计费用 $29.23M $24.61M $21.60M $21.60M $20.96M
短期债务及融资租赁负债 $1.34M $1.56M $1.53M $1.53M $1.50M
-一年内到期融资租赁负债 $1.34M $1.56M $1.53M $1.53M $1.50M
非流动负债合计 $8.37M $9.18M $9.61M $9.61M $9.99M
长期债务及融资租赁负债 $5.08M $5.93M $6.41M $6.41M $6.83M
-长期融资租赁负债 $5.08M $5.93M $6.41M $6.41M $6.83M
其他非流动负债 $3.29M $3.25M $3.20M $3.20M $3.16M
股东权益合计 $1.24B $1.34B $581.76M $581.76M $559.51M
股东权益 $1.24B $1.34B $581.76M $581.76M $559.51M
股本 $2.43B $2.42B $1.60B $1.60B $1.48B
-普通股 $2.43B $2.42B $1.60B $1.60B $1.48B
资本公积 $276.85M $264.88M $228.23M $228.23M $223.78M
留存收益 -$1.46B -$1.35B -$1.25B -$1.25B -$1.14B
不影响留存收益的损益 -$2.66M -$1.21M $335,000.00 $335,000.00 $477,000.00
-累计折旧 – – -$15.45M -$15.45M –

现金流量表

项目 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
经营活动现金流 -$95.39M -$88.90M -$279.12M -$81.48M -$71.75M
持续经营经营活动现金流净额 -$95.39M -$88.90M -$279.12M -$81.48M -$71.75M
持续经营净利润 -$110.74M -$102.30M -$345.91M -$105.26M -$90.90M
持续经营损益 -$725,000.00 -$604,000.00 $698,000.00 $179,000.00 $29,000.00
折旧、折耗与摊销 $558,000.00 $587,000.00 $2.54M $611,000.00 $641,000.00
递延税款 -$1.94M $447,000.00 -$3.20M -$1.11M -$701,000.00
其他非现金项目 $1.20M -$539,000.00 $1.31M $334,000.00 $330,000.00
营运资金变动 $2.43M -$3.38M $4.36M $8.97M $4.96M
-应收款变动 -$467,000.00 $205,000.00 $104,000.00 -$559,000.00 $283,000.00
-预付资产变动 -$2.50M -$1.48M -$3.16M $6.63M -$3.37M
-应付账款及应计费用变动 $5.72M -$1.80M $5.51M $3.19M $5.23M
-其他流动负债变动 -$317,000.00 -$302,000.00 $1.90M $2.86M -$337,000.00
投资活动现金流净额 -$331.24M -$407.28M $218.00M $62.70M $38.53M
持续经营投资活动现金流净额 -$331.24M -$407.28M $218.00M $62.70M $38.53M
固定资产购置及出售净额 -$275,000.00 -$133,000.00 -$799,000.00 -$318,000.00 -$281,000.00
投资购置及出售净额 -$330.96M -$407.15M $218.80M $63.02M $38.81M
筹资活动现金流 $26,000.00 $843.01M $117.11M $113.54M $2.36M
持续经营筹资活动现金流净额 $26,000.00 $843.01M $117.11M $113.54M $2.36M
普通股发行净额 $0.00 $837.53M $112.15M – –
股票期权行使所得 $26,000.00 $5.49M $4.96M $1.39M $2.36M
期末现金余额 $119.53M $545.87M $199.16M $199.16M $104.51M
现金净变动 -$426.60M $346.83M $55.99M $94.75M -$30.86M
期初现金余额 $545.87M $199.16M $142.71M $104.51M $135.38M
汇率变动影响 $262,000.00 -$130,000.00 $458,000.00 -$104,000.00 -$6,000.00
自由现金流 -$95.67M -$89.03M -$279.92M -$81.80M -$72.03M

讨论区

暂无评论——快来第一个聊聊 XENE。

登录后参与讨论。

Scroll to Top